|Articles|August 1, 1998

August 1998
Volume 4
Issue 8

Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project

Author(s)Susan D. Horn, PhD, Phoebe D. Sharkey, PhD, Cheryl Phillips-Harris, MD

Download PDF: Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project

Articles in this issue

almost 28 years ago

Article

The Impact of Reimbursement Changes for Intracoronary Stents on Providers and Medicare

almost 28 years ago

Article

The Cost of Inpatient Endometriosis Treatment: An Analysis Based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample

almost 28 years ago

Article

Identification and Assessment of High-Risk Seniors

almost 28 years ago

Article

Outpatient Antidepressant Utilization in a Dutch Sick Fund

almost 28 years ago

Article

Inborn Errors of Metabolism: Medical and Administrative "Orphans"

almost 28 years ago

Article

Treatment Options for Prostate Cancer: Part 2 -- Early and Late Stage and Hormone Refractory Disease

almost 28 years ago

Article

Generic Drug Product Equivalence: Current Status

almost 28 years ago

Article

Correspondence regarding, "A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia"

almost 28 years ago

Article

The Clinical Value of Commonly Used Spinal Fluid Diagnostic Studies in the Evaluation of Patients with Suspected Multiple Sclerosis

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project

Articles in this issue

Related Content

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Trending on AJMC

GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale

ACA Enrollment Erosion Deepens After Open Enrollment Ends

FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19

Shields Health Solutions Partners With Baptist Health on Specialty Pharmacy

AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD